Other News

Boston Scientific (BSX) to Acquire SoCal’s Apama Medical in $300 Million Deal

MARLBOROUGH, Mass., Oct. 2, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Apama Medical Inc., a privately-held company that is developing the Apama Radiofrequency (RF) Balloon Catheter System for the treatment of atrial fibrillation (AF). The transaction consists of $175 million in cash up-front and a maximum […]

Jeffrey H. Burbank Joins CryoLife Board of Directors

ATLANTA, Oct. 2, 2017 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced the appointment of Jeffrey H. Burbank to its Board of Directors effective September 29, 2017. Pat Mackin, Chairman, President, and Chief Executive Officer, commented, “Jeff has over 30 years of in-depth management […]

Celebrating The 20th Anniversary Of The W. L. Gore & Associates EXCLUDER Device

FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) today announced the 20th anniversary of the first implant of the GORE® EXCLUDER® AAA Endoprosthesis, the most-studied** endovascular aneurysm repair (EVAR) device on the market, with more than 300,000 patients treated* worldwide. The GORE EXCLUDER Device provides physicians with a proven and durable option to […]

Essential Medical Completes Enrollment In US IDE Trial For The MANTA Large Bore Vascular Closure Device Used Primarily In Percutaneous Heart Valve Replacement Procedures

MALVERN, Pennsylvania, Oct. 2, 2017 /PRNewswire/ — Essential Medical today announced the completion of enrollment in the US pivotal IDE trial of the MANTA large bore vascular closure device. “Our team is thrilled with the enthusiasm of investigators and sites that accelerated MANTA study enrollment,” commented Todd Sorzano, Director of Operations at Essential […]

FDA Warns Physicians on Endoleaks With Stent Grafts

Endovascular Graft Systems: Letter to Health Care Providers – Type III Endoleaks Associated with Use [Posted 09/28/2017] AUDIENCE: Risk Manager, Surgery, Cardiology, Radiology ISSUE: The FDA is evaluating recent information regarding Type IIIa and IIIb endoleaks with the use of endovascular graft systems indicated for a procedure known as endovascular […]

CHF Solutions Initiates International Distribution with UK-Based APC Cardiovascular Ltd.

EDEN PRAIRIE, Minn., Sept. 28, 2017 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ:CHFS) announced today that it is initiating international distribution of its products by entering into a distribution agreement with APC Cardiovascular Ltd., a distributor based in the United Kingdom. APC Cardiovascular will market CHF Solutions’ Aquadex FlexFlow® System and will serve as CHF Solutions authorized service provider […]

Medtronic HeartWare(TM) HVAD(TM) System Approved for Destination Therapy

DUBLIN – September 27, 2017 – Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) approval for its HeartWare(TM) HVAD(TM) System as a destination therapy for patients with advanced heart failure who are not candidates for heart transplants. The HVAD System, a left ventricular assist device or LVAD, […]

Newly Published Peer Reviewed Study Reveals Benefits Of ClearFlow’s PleuraFlow ACT System

ANAHEIM, Calif.–(BUSINESS WIRE)–ClearFlow Inc., a medical device company based in Anaheim, California, has announced the publication of significantly positive results in a study evaluating the company’s PleuraFlow® Active Clearance Technology® System. Data from a peer-reviewed clinical study indicating a marked reduction in Postoperative Atrial Fibrillation (POAF) among patients with active clearance of chest […]

LivaNova (LIVN) And MicroPort Scientific (MCRPF) Announce The Approval Of Rega Pacemakers By The China Food And Drug Administration

LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) and MicroPort Scientific Corporation (HK:00853) (“MicroPort”), today announced that the companies’ Shanghai-based joint venture MicroPort Sorin Cardiac Rhythm Management Co. Ltd. (“MSC” or the “joint venture”) obtained approval for its family of RegaTM pacemakers from the China Food and Drug Administration. Not only are Rega pacemakers […]